SANOFI US SERVICES INC. for SANOFI US SERVICES INC
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
General discussions regarding the reauthorization of the Prescription Drug User Fee Act (PDUFA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS New | — |
| MARYANNE DOLBEARE DUNLAP New | — |
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
| AMY L REDL New | — |
Medicare/Medicaid MMM
Provisions related to a mens rea requirement in HR675 "Strengthening Medicare Anti-Fraud Measures Act of 2011"
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS New | — |
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
Taxation/Internal Revenue Code TAX
Extension of the U.S. R&D tax credit and all such provision in HR942 "The American Research and Competitiveness Act of 2011"
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
| ANN TAYLOR | — |
Copyright/Patent/Trademark CPT
S23 "America Invents Act" (formerly "Patent Reform Act of 2011"), provisions related to first to file, inter parties review and supplemental re-examination; intellectual property provisions in the pending South Korea, Columbia and Panama Free Trade Agreements
Foreign entity interest: Intellectual property provisions in the pending Free Trade Agreements impact the property rights of sanofi-aventis SA, the foreign parent company identified on Form LD-1.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS New | (1997-98) |
| TIMOTHY CLARK | — |
| MARYANNE DOLBEARE DUNLAP New | Thomas J. Bliley, Jr. (1991) |
| EDDIE D EVANS | — |
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
Health Issues HCR
Comparative effectiveness, including issues related to the Patient Centered Research Insitute, issues related to limitations on the use of Health Savings Accounts for over-the-counter medicines, repeal and defunding efforts, & general issues regarding implementation of HR3590 "The Patient Protection and Affordable Care Act" including the Medication Therapy Management Program transitions of care; awareness and issues related to patient access to diabetes care; awareness and issues related to patient access to atrial fibrillation care; all provisions of S668 "Health Care Bureaucrats Elimination Act" and HR452 "Medicare Decisions Accountability Act of 2011"; issues related to importation of prescription medicines; issues related to efforts to move pseudoephedrine products to prescription drug status; section 401 of S174 "Healthy Lifestyles and Prevention (HeLP) America Act"; and issues related to pandemic influenza and biodefense funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS New | — |
| TIMOTHY CLARK | — |
| MARYANNE DOLBEARE DUNLAP New | — |
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
| AMY L REDL New | — |
| PETER RUBIN | — |
| ANN TAYLOR | — |
Torts TOR
Punitive damages provisions in HR5 "Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act; and general issues related to efforts to reform the Vaccine Injury Compensation Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS New | — |
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
| AMY L REDL New | — |
| ANN TAYLOR | — |
Affiliated organisations
| Organisation | Location |
|---|---|
| SANOFI PASTEUR, INC. | Swiftwater, PA, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.